PRCT.NASDAQProcept Biorobotics CORP
10-K/A: PROCEPT BioRobotics Files Amendment to 10-K to Include Insider Trading Policy
Sentiment:
10-K/A Amendment
PROCEPT BioRobotics Corporation files an amendment to its annual report to include its Insider Trading Compliance Policy and Procedures, which was inadvertently omitted from the original filing.
Summary
- PROCEPT BioRobotics Corporation is filing an amendment to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
- The amendment's sole purpose is to include Exhibit 19.1, the company's Insider Trading Compliance Policy and Procedures, which was unintentionally left out of the original filing.
- No other changes have been made to the original filing, and the amendment does not modify or update any financial or other information.
- The company had 54,818,700 shares of common stock outstanding as of February 20, 2025.
- The aggregate market value of shares held by non-affiliates as of June 30, 2024, was approximately $3.1 billion.
Sentiment
Score: 7
Explanation: The document is a routine amendment to include a missing exhibit. The sentiment is neutral to slightly positive as the company is taking corrective action.
Positives
- The company is taking corrective action to ensure all required exhibits are included in its filings.
Negatives
- The Insider Trading Compliance Policy and Procedures was inadvertently omitted from the original filing.
Risks
- Failure to comply with insider trading regulations could result in legal and reputational damage to the company.
- The company's stock price could be negatively impacted if there are any violations of the Insider Trading Compliance Policy and Procedures.
Industry Context
Insider trading policies are standard practice for publicly traded companies to ensure compliance with securities laws and maintain investor confidence.
Comparison to Industry Standards
- Most publicly traded companies have insider trading policies similar to the one PROCEPT BioRobotics has filed.
- These policies typically outline restrictions on trading company securities while in possession of material non-public information.
- Companies like Medtronic, Stryker, and Boston Scientific, which are in the medical device industry, also have comprehensive insider trading policies.
Stakeholder Impact
- The inclusion of the Insider Trading Compliance Policy and Procedures aims to protect shareholders by preventing illegal trading activities.
- Employees are required to comply with the policy, ensuring ethical conduct and maintaining the company's reputation.
Key Dates
| Date | Description |
|---|---|
| August 7, 2018 | Offer Letter, by and between the Registrant and Kevin Waters, dated as of August 7, 2018 |
| May 15, 2018 | Offer Letter, by and between the Registrant and Alaleh Nouri, dated as of May 15, 2018 |
| March 21, 2019 | Offer Letter, by and between the Registrant and Hisham Shiblaq, dated as of March 21, 2019 |
| March 14, 2019 | Confidential Exclusive Patent License and Covenant Not to Sue, by and between the Registrant and HydroCision, Inc., dated March 14, 2019 |
| September 13, 2019 | Amended and Restated Exclusive License Agreement, by and between the Registrant and AquaBeam LLC, dated as of September 13, 2019 |
| January 31, 2020 | Offer Letter, by and between the Registrant and Reza Zadno, Ph.D., dated as of January 31, 2020 |
| September 21, 2021 | Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the registrants Current Report on Form 8-K (File No. 001-40797) filed on September 21, 2021) |
| September 21, 2021 | Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the registrants Current Report on Form 8-K (File No. 001-40797) filed on September 21, 2021) |
| September 17, 2021 | Amended and Restated Change of Control Severance Agreement, by and between the Registrant and Reza Zadno, Ph.D., dated September 17, 2021 |
| September 17, 2021 | Amended and Restated Change of Control Severance Agreement, by and between the Registrant and Kevin Waters, dated September 17, 2021 |
| September 17, 2021 | Amended and Restated Change of Control Severance Agreement, by and between the Registrant and Hisham Shiblaq, dated September 17, 2021 |
| September 17, 2021 | Amended and Restated Change of Control Severance Agreement, by and between the Registrant and Alaleh Nouri, dated September 17, 2021 |
| December 31, 2021 | Lease, by and between the Registrant and 150-180 Baytech Drive CA Owner, LLC, dated December 31, 2021 |
| October 6, 2022 | Loan and Security Agreement, by and among Canadian Imperial Bank of Commerce, the Registration, and each Borrower and Guarantor from time to time, dated as of October 6, 2022 |
| June 1, 2023 | First Amendment to Loan and Security Agreement, by and between Canadian Imperial Bank of Commerce and the Registrant, dated June 1, 2023 |
| February 27, 2025 | Original Filing Date of the Annual Report on Form 10-K |
| April 11, 2025 | Date of Amendment No. 1 filing |
Keywords
Insider Trading, Compliance Policy, Amendment, Form 10-K, PROCEPT BioRobotics, Securities, Financial Reporting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.